Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2014
10/30/2014US20140322249 Dna vaccines against tumor growth and methods of use thereof
10/30/2014US20140322248 Dual Specific Immunotoxin for Brain Tumor Therapy
10/30/2014US20140322242 Materials and methods for the prevention and treatment of cancer
10/30/2014US20140322240 Malaria vaccine
10/30/2014US20140322237 Neurodegenerative diseases and methods of modeling
10/30/2014US20140322233 Anti-gcc antibody molecules and related compositions and methods
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/30/2014US20140322230 Induction of mucosal tolerance to antigens
10/30/2014US20140322225 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
10/30/2014US20140322221 Multivalent antibodies and uses therefor
10/30/2014US20140322220 Anti-FGFR2 Antibodies and Uses Thereof
10/30/2014US20140322213 Pharmaceutical Composition for the Treatment of Type-1 Diabetes
10/30/2014US20140322208 Treatment of hematologic malignancies with an anti-cxcr4 antibody
10/30/2014US20140322207 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
10/30/2014US20140322203 Formulations with reduced oxidation
10/30/2014US20140322202 TREATMENT WITH ANTI ErbB2 ANTIBODIES
10/30/2014US20140322201 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies
10/30/2014US20140322200 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody
10/30/2014US20140322163 Neutralizing antibodies to hiv-1 and their use
10/30/2014US20140322161 Anti-il-6 vaccine composition
10/30/2014US20140322160 Method and composition for altering a b cell mediated pathology
10/30/2014US20140322134 Treatment and Imaging Methods Using Antibodies to Aminophospholipids
10/30/2014US20140322131 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma
10/30/2014US20140322130 Specific binding proteins and uses thereof
10/28/2014US8871911 Compositions and methods for the diagnosis and treatment of tumor
10/28/2014US8871908 Antibodies specific for Trop-2 and their uses
10/28/2014US8871902 Immunogenic POTE peptides and methods of use
10/28/2014US8871901 Phage constructs, sequences and antigenic compositions for immunocontraception of animals
10/28/2014US8871816 Methods for producing vaccine adjuvants
10/28/2014US8871732 Immunostimulatory sequence oligonucleotides and methods of using the same
10/28/2014US8871729 Treatment of CNS conditions
10/28/2014US8871725 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
10/28/2014US8871719 Modified MELK peptides and vaccines containing the same
10/28/2014US8871708 Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles
10/28/2014US8871491 Capsular gram-positive bacteria bioconjugate vaccines
10/28/2014US8871487 Compositions, methods and uses for inducing viral growth
10/28/2014US8871467 Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
10/28/2014US8871447 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
10/28/2014US8871436 Immunostimulatory oligonucleotides and uses thereof
10/28/2014US8871250 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
10/28/2014US8871226 Methods and compositions for the treatment and diagnosis of cancer
10/28/2014US8871225 Canine leishmania vaccine
10/28/2014US8871224 Botulinum toxin therapy for skin disorders
10/28/2014US8871223 HSV-1 and HSV-2 vaccines and methods of use thereof
10/28/2014US8871222 Recombinant Flavivirus vaccines
10/28/2014US8871221 Methods of stimulating protective immunity employing Dengue viral antigens
10/28/2014US8871220 Newcastle disease virus vectored avian vaccines
10/28/2014US8871219 Recombinant vectors based on the modified vaccinia ankara virus (MVA) as preventive and therapeutic vaccines against AIDS
10/28/2014US8871216 Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
10/28/2014US8871215 Flagellin related polypeptides and uses thereof
10/28/2014US8871214 Detoxified Escherichia coli immunogens
10/28/2014US8871213 Prevention, treatment and diagnosis of P. gingivalis infection
10/28/2014US8871212 Amyloid-beta polypeptide vaccine
10/28/2014US8871211 Cancer vaccines and vaccination methods
10/28/2014US8871209 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A
10/28/2014US8871207 Neutralizing anti-influenza A virus antibodies and uses thereof
10/28/2014US8871205 Methods and compositions for the treatment of immune disorders
10/28/2014US8871203 Method of treating a pathological syndrome and a pharmaceutical agent
10/28/2014US8871202 Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
10/28/2014US8871201 Stabilizing formulations
10/28/2014US8871199 Compositions and methods to promote implantation and engrafment of stem cells
10/28/2014US8871193 Viral vectors and their use in therapeutic methods
10/28/2014US8871192 IL-1F8 polypeptides
10/23/2014US20140316111 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines
10/23/2014US20140316110 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines
10/23/2014US20140315314 Engineered listeria and methods of use thereof
10/23/2014US20140314865 Vaccine Nanotechnology
10/23/2014US20140314858 Ipnv-isav bivalent vaccine using a virus-like particle-based platform and methods of using the same
10/23/2014US20140314852 Nanoparticulate systems prepared from sorbitan esters
10/23/2014US20140314839 Controlled-release peptide compositions and uses thereof
10/23/2014US20140314837 Vaccine Therapy
10/23/2014US20140314834 Gla monotherapy for use in cancer treatment
10/23/2014US20140314816 Stabilized stat3 decoy oligonucleotides and uses therefore
10/23/2014US20140314814 Antigen presenting cancer vaccine
10/23/2014US20140314813 Clostridium difficile lipoteichoic acid and uses thereof
10/23/2014US20140314812 Live, attenuated streptococcus pneumoniae strain and vaccine for protection against pneumococcal disease
10/23/2014US20140314811 Herpes simplex virus vaccines
10/23/2014US20140314810 Compositions Containing Purine and Pyrimidine Nucleosides, Peptides, and Manganese and Their Uses
10/23/2014US20140314807 Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof
10/23/2014US20140314806 Potency test for vaccine formulations
10/23/2014US20140314805 Multivalent pneumococcal polysaccharide-protein conjugate composition
10/23/2014US20140314804 Compositions including beta-glucans and methods of use
10/23/2014US20140314803 Compositions and methods related to p6
10/23/2014US20140314802 Novel compositions and methods
10/23/2014US20140314800 Beta-lactoglobulin peptides for treating cow's milk protein allergy
10/23/2014US20140314799 Methods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling
10/23/2014US20140314791 Methods of treating cancer
10/23/2014US20140314784 Anti-cxcr4 antibodies and methods of use
10/23/2014US20140314783 Methods for suppressing allergic reactions
10/23/2014US20140314781 Formulation of human antibodies for treating tnf-alpha associated disorders
10/23/2014US20140314780 Compositions Using Antibodies Directed to GPNMB and Uses Thereof
10/23/2014US20140314778 Formulations with reduced oxidation
10/23/2014US20140314776 Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
10/23/2014US20140314775 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment of anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
10/23/2014US20140314774 Her3 antibodies and uses thereof
10/23/2014US20140314773 Compositions and methods for treating alzheimer's disease
10/23/2014US20140314771 Combination therapy of antibodies against human csf-1r and tlr9 agonist
10/23/2014US20140314769 Neutralizing Antibodies And Methods Of Use Thereof
10/23/2014US20140314764 Bi-specific antibodies for medical use
10/23/2014US20140314762 Stimulation of Ovarian Follicle Development and Oocyte Maturation
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 1823